Özcan Met

749 total citations · 1 hit paper
9 papers, 547 citations indexed

About

Özcan Met is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Özcan Met has authored 9 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Özcan Met's work include CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immunotherapy and Immune Responses (4 papers). Özcan Met is often cited by papers focused on CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immunotherapy and Immune Responses (4 papers). Özcan Met collaborates with scholars based in Denmark, Netherlands and Canada. Özcan Met's co-authors include Inge Marie Svane, Cathrine Lund Lorentzen, John B.A.G. Haanen, Marco Donia, Troels Holz Borch, Morten Nielsen, Joachim Stoltenborg Granhøj, Magnus Pedersen, Helle Westergren Hendel and Marie Christine Wulff Westergaard and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.

In The Last Decade

Özcan Met

8 papers receiving 539 citations

Hit Papers

Clinical advances and ongoing trials of mRNA vaccines for... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özcan Met Denmark 5 333 288 271 58 37 9 547
Irene Olivera Spain 12 360 1.1× 259 0.9× 139 0.5× 55 0.9× 53 1.4× 24 544
Tiziano Ingegnere Italy 11 391 1.2× 280 1.0× 161 0.6× 37 0.6× 40 1.1× 15 604
Gina Choe United States 8 353 1.1× 158 0.5× 193 0.7× 41 0.7× 28 0.8× 11 566
Diana G. Martinez United States 8 482 1.4× 249 0.9× 150 0.6× 24 0.4× 35 0.9× 10 630
Céline Robert-Tissot United States 10 255 0.8× 191 0.7× 188 0.7× 60 1.0× 27 0.7× 15 430
Katy J. McCann United Kingdom 10 311 0.9× 180 0.6× 246 0.9× 39 0.7× 34 0.9× 16 563
Yolanda C. Nesbeth United States 8 495 1.5× 249 0.9× 147 0.5× 25 0.4× 34 0.9× 10 625
Mara Valentini Italy 5 450 1.4× 379 1.3× 125 0.5× 47 0.8× 42 1.1× 5 643
Miao-La Ke China 10 249 0.7× 266 0.9× 145 0.5× 48 0.8× 9 0.2× 11 476
Nikki M. Loof Netherlands 12 447 1.3× 314 1.1× 181 0.7× 18 0.3× 23 0.6× 16 588

Countries citing papers authored by Özcan Met

Since Specialization
Citations

This map shows the geographic impact of Özcan Met's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özcan Met with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özcan Met more than expected).

Fields of papers citing papers by Özcan Met

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özcan Met. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özcan Met. The network helps show where Özcan Met may publish in the future.

Co-authorship network of co-authors of Özcan Met

This figure shows the co-authorship network connecting the top 25 collaborators of Özcan Met. A scholar is included among the top collaborators of Özcan Met based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özcan Met. Özcan Met is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Petersen, David L., Marie Just Mikkelsen, Özcan Met, et al.. (2024). Analyzing functional heterogeneity of effector cells for enhanced adoptive cell therapy applications. Immuno-Oncology Technology. 24. 100738–100738.
2.
Lorentzen, Cathrine Lund, John B.A.G. Haanen, Özcan Met, & Inge Marie Svane. (2022). Clinical advances and ongoing trials of mRNA vaccines for cancer treatment. The Lancet Oncology. 23(10). e450–e458. 346 indexed citations breakdown →
3.
Granhøj, Joachim Stoltenborg, et al.. (2022). Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions. Expert Opinion on Biological Therapy. 22(5). 627–641. 50 indexed citations
4.
Kverneland, Anders, Christopher A. Chamberlain, Troels Holz Borch, et al.. (2021). Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types. Journal for ImmunoTherapy of Cancer. 9(10). e003499–e003499. 45 indexed citations
5.
Kaae, Jeanette, Özcan Met, Inge Marie Svane, et al.. (2020). Efficacy and safety of IO103 a novel anti PD-L1 vaccine in basal cell carcinoma.. Journal of Clinical Oncology. 38(15_suppl). e22070–e22070. 3 indexed citations
6.
Müller, Klaus, Marianne Ifversen, Katrine Kielsen, et al.. (2019). [Chimeric antigen receptor T-cell therapy].. PubMed. 181(20A). 1 indexed citations
7.
Pedersen, Magnus, Marie Christine Wulff Westergaard, Katy Milne, et al.. (2018). Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study. OncoImmunology. 7(12). e1502905–e1502905. 89 indexed citations
8.
Borch, Troels Holz, Per Kongsted, Magnus Pedersen, et al.. (2018). Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor induction in checkpoint inhibitor resistant metastatic melanoma patients. Annals of Oncology. 29. viii402–viii402. 2 indexed citations
9.
Pedersen, Magnus, Marie Christine Wulff Westergaard, Morten Nielsen, et al.. (2017). Adoptive cell therapy with tumor-infiltrating lymphocytes for patients with metastatic ovarian cancer: A pilot study. Annals of Oncology. 28. v407–v407. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026